Partnership
US$ 22.57
glp-1 nasal spray Tirzepatide HypoSpray® FDA approves first nasal glucagon
Description
GLP-1 receptor agonists like semaglutide improve weight loss and metabolic health, but they require special consideration before scheduled surgery
In reality, the roundabout money trail keeps patients in the dark about the true cost of coveragea disconnect that relieves incentives for insurers to negotiate better deals with providers
2025 Aug 26;68(Suppl 1):S982
You have a fever or signs of a systemic infection
